Biocyte
FranceEntry
2018
Hold
5yr
Exit
2023
Who owns Biocyte?
Biocyte was owned by Audacia through Audacia Capital Développement IV (2023 vintage) from 2018 to 2023, exited via Trade Sale. Across its history, Biocyte has been through 2 private equity ownership periods, detailed in the timeline below.
Buyer identity available on Pro.
Hand-verified · updated 2026-04-21
Most recent investor
AudaciaAudacia Capital Développement IV · 2023 · Growth
2 ownership periods · full history below
Key facts
Key takeaways
- ·Fully exited in 2023.
- ·Average hold across 2 realized cycles: 5 years.
Ownership history
2 ownership periods · co-invest detected
Exited
Last exited in 2023 to .
Co-invest · 2 holders · 2018 · 2023
SOFIPACA - Groupe Crédit AgricoleExited 2023
2018 · 2023(5yr) · SOFIPACA Evergreen · 1991 · Growth
Trade Sale · to
MOIC
–
AudaciaExited 2023
2018 · 2023(5yr) · Audacia Capital Développement IV · 2023 · Growth
Trade Sale · to
MOIC
–
More from Audacia Capital Développement IV
Other portfolio companies in the same fund.
More PE-backed in Consumer
Comparable consumer deals from other GPs.
Ireland
USTrack Biocyte
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Biocyte?
5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Biocyte.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue